GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » E10

Sopharma AD-Sofia (XBUL:SFA) E10 : лв0.52 (As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Sopharma AD-Sofia E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sopharma AD-Sofia's adjusted earnings per share data for the three months ended in Jun. 2024 was лв0.097. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is лв0.52 for the trailing ten years ended in Jun. 2024.

During the past 12 months, Sopharma AD-Sofia's average E10 Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-12-11), Sopharma AD-Sofia's current stock price is лв5.72. Sopharma AD-Sofia's E10 for the quarter that ended in Jun. 2024 was лв0.52. Sopharma AD-Sofia's Shiller PE Ratio of today is 11.00.

During the past 13 years, the highest Shiller PE Ratio of Sopharma AD-Sofia was 14.65. The lowest was 9.04. And the median was 11.06.


Sopharma AD-Sofia E10 Historical Data

The historical data trend for Sopharma AD-Sofia's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia E10 Chart

Sopharma AD-Sofia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.46 0.47 0.50

Sopharma AD-Sofia Quarterly Data
Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.50 0.50 0.54 0.52

Competitive Comparison of Sopharma AD-Sofia's E10

For the Medical Distribution subindustry, Sopharma AD-Sofia's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia's Shiller PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Shiller PE Ratio falls into.



Sopharma AD-Sofia E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sopharma AD-Sofia's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.097/132.5538*132.5538
=0.097

Current CPI (Jun. 2024) = 132.5538.

Sopharma AD-Sofia Quarterly Data

per share eps CPI Adj_EPS
201406 -0.050 100.560 -0.066
201409 0.010 100.428 0.013
201412 0.000 99.070 0.000
201503 0.130 99.621 0.173
201506 0.136 100.684 0.179
201509 -0.024 100.392 -0.032
201512 -0.020 99.792 -0.027
201603 0.081 100.470 0.107
201606 0.123 101.688 0.160
201609 0.041 101.861 0.053
201612 0.145 101.863 0.189
201703 0.132 102.862 0.170
201706 0.092 103.349 0.118
201709 0.029 104.136 0.037
201712 -0.090 104.011 -0.115
201803 0.098 105.290 0.123
201806 0.067 106.317 0.084
201809 0.049 106.507 0.061
201812 0.011 105.998 0.014
201903 0.250 107.251 0.309
201906 0.057 108.070 0.070
201909 0.088 108.329 0.108
201912 0.423 108.420 0.517
202006 0.252 108.767 0.307
202009 0.010 109.815 0.012
202012 0.063 109.897 0.076
202103 0.140 111.754 0.166
202106 0.112 114.631 0.130
202109 0.140 115.734 0.160
202112 0.310 117.630 0.349
202203 0.170 121.301 0.186
202206 0.190 125.017 0.201
202209 0.200 125.227 0.212
202212 0.010 125.222 0.011
202303 0.260 127.348 0.271
202306 0.250 128.729 0.257
202309 0.090 129.860 0.092
202312 0.090 129.419 0.092
202403 0.230 131.776 0.231
202406 0.097 132.554 0.097

Add all the adjusted EPS together and divide 10 will get our e10.


Sopharma AD-Sofia  (XBUL:SFA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sopharma AD-Sofia's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=5.72/0.52
=11.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sopharma AD-Sofia was 14.65. The lowest was 9.04. And the median was 11.06.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sopharma AD-Sofia E10 Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma AD-Sofia Business Description

Traded in Other Exchanges
Address
5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.

Sopharma AD-Sofia Headlines

No Headlines